Upadacitinib (ABT-494)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders with an IC50 of 43 nM. IC50 & Target: IC50: 43 nM (JAK1), 200 nM (JAK2) | ||
---|---|---|---|
Targets |
|
Catalog Num | A18316 |
---|---|
Formula | C17H19F3N6O |
Molecular Weight | 380.37 |
CAS Number | 1310726-60-3 |
SMILES | CCC1CN(CC1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F |
Synonyms | ABT 494, ABT494 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 66 mg/mL (173.51 mM) | |
Water | Insoluble | ||
Ethanol | 66 mg/mL (173.51 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 26.29 mL | 131.45 mL | 262.9 mL |
0.5 mM | 5.26 mL | 26.29 mL | 52.58 mL |
1 mM | 2.63 mL | 13.15 mL | 26.29 mL |
5 mM | 0.53 mL | 2.63 mL | 5.26 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2